ATAGI statement on the use of Novavax COVID-19 vaccine (Nuvaxovid)

Australian Government

24 January 2022 - ATAGI recommends that Novavax COVID-19 vaccine can be used for the primary course of COVID-19 vaccination in people aged 18 or older.

The recommended schedule for administration is 2 doses, a minimum of 3 weeks apart.

Read ATAGI statement

Michael Wonder

Posted by:

Michael Wonder